PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
CIK 1249675
Transactions on file
27
Open-market buys
3
Win rate (buys)
67%
3 scored
Avg % since filing (buys)
+74.8%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-27 | 2026-08-26 | IMTX Immatics N.V. | Buy | 863,060 | $7.50M | -3.7% | open → | |
| 2026-07-23 | 2026-07-20 | FRNM Freenome, Inc. | Grant | 5,500,000 | $55.00M | +61.9% | open → | |
| 2026-07-13 | 2026-06-17 | KARD Kardigan, Inc. | Grant | 20,706 | $0.00 | — | open → | |
| 2026-04-23 | 2026-04-17 | MGTX MeiraGTx Holdings plc | Grant | 555,555 | $5.00M | +23.4% | open → | |
| 2025-02-14 | 2025-01-22 | ADGM Adagio Medical Holdings, Inc. | Director10% | Grant | 64,167 | — | — | open → |
| 2025-02-21 | 2025-02-19 | SLDB Solid Biosciences Inc. | Director10% | Buy | 5,000,000 | $20.15M | +113.9% | open → |
| 2025-04-07 | 2025-04-03 | ALDX Aldeyra Therapeutics, Inc. | 10% | Sale | 3,400,000 | $4.83M | +45.8% | open → |
| 2025-04-29 | 2025-04-29 | ACRV Acrivon Therapeutics, Inc. | 10% | Sale | 250,000 | $352.5K | +46.1% | open → |
| 2025-04-29 | 2025-04-28 | ACRV Acrivon Therapeutics, Inc. | 10% | Sale | 215,283 | $335.8K | +32.1% | open → |
| 2025-04-29 | 2025-04-25 | ACRV Acrivon Therapeutics, Inc. | 10% | Sale | 1,054,669 | $2.06M | +5.6% | open → |
| 2025-05-01 | 2025-05-01 | ACRV Acrivon Therapeutics, Inc. | 10% | Sale | 298,886 | $400.5K | +53.7% | open → |
| 2025-05-01 | 2025-04-30 | ACRV Acrivon Therapeutics, Inc. | 10% | Sale | 437,881 | $617.4K | +46.1% | open → |
| 2025-12-23 | 2025-12-23 | ATHA Athira Pharma, Inc. | Director10% | Grant | 329,756 | $2.09M | — | open → |
| 2025-12-23 | 2025-12-23 | ATHA Athira Pharma, Inc. | Director10% | Grant | 989,270 | $6.28M | — | open → |
| 2025-11-13 | 2025-11-13 | LYRA Lyra Therapeutics, Inc. | Sale | 3,213 | $12.5K | -85.9% | open → | |
| 2025-11-13 | 2025-11-13 | LYRA Lyra Therapeutics, Inc. | Sale | 28,597 | $111.5K | -85.9% | open → | |
| 2025-11-13 | 2025-11-12 | LYRA Lyra Therapeutics, Inc. | Sale | 883 | $3.6K | -86.5% | open → | |
| 2025-11-13 | 2025-11-12 | LYRA Lyra Therapeutics, Inc. | Sale | 7,862 | $31.9K | -86.5% | open → | |
| 2025-11-13 | 2025-11-11 | LYRA Lyra Therapeutics, Inc. | Sale | 537 | $2.3K | -87.3% | open → | |
| 2025-11-13 | 2025-11-11 | LYRA Lyra Therapeutics, Inc. | Sale | 4,783 | $20.6K | -87.3% | open → | |
| 2025-11-10 | 2025-11-10 | LYRA Lyra Therapeutics, Inc. | Sale | 1,869 | $8.5K | -87.9% | open → | |
| 2025-11-10 | 2025-11-10 | LYRA Lyra Therapeutics, Inc. | Sale | 16,633 | $75.5K | -87.9% | open → | |
| 2025-11-10 | 2025-11-07 | LYRA Lyra Therapeutics, Inc. | Sale | 1,993 | $9.5K | -88.4% | open → | |
| 2025-11-10 | 2025-11-07 | LYRA Lyra Therapeutics, Inc. | Sale | 17,746 | $84.2K | -88.4% | open → | |
| 2025-11-10 | 2025-11-06 | LYRA Lyra Therapeutics, Inc. | Sale | 3,247 | $16.8K | -89.4% | open → | |
| 2025-11-10 | 2025-11-06 | LYRA Lyra Therapeutics, Inc. | Sale | 28,902 | $149.7K | -89.4% | open → | |
| 2025-08-05 | 2025-08-01 | OBIO Orchestra BioMed Holdings, Inc. | 10% | Buy | 700,000 | $1.93M | +114.2% | open → |
